Skip to main content

Articles

Page 61 of 76

  1. Development of HPV-associated cancers not only depends on efficient negative regulation of cell cycle control that supports the accumulation of genetic damage, but also relies on immune evasion that enable the...

    Authors: Patrizia Vici, Luciano Mariani, Laura Pizzuti, Domenico Sergi, Luigi Di Lauro, Enrico Vizza, Federica Tomao, Silverio Tomao, Claudia Cavallotti, Francesca Paolini and Aldo Venuti
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:29
    Content type: Review Published on:

  2. Bone scanning (BS), liver ultrasonography (LUS), and chest radiography (CXR) are commonly recommended for baseline staging in patients with newly diagnosed breast cancer. The purpose of this study is to demons...

    Authors: Xuesong Chen, Lichun Sun, Yingying Cong, Tingting Zhang, Qiushi Lin, Qingwei Meng, Hui Pang, Yanbin Zhao, Yu Li, Li Cai and Xiaoqun Dong
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:28
    Content type: Research Published on:

  3. In osteosarcoma, the presence of tumor-infiltrating macrophages positively correlates with patient survival in contrast to the negative effect of tumor-associated macrophages in patients with other tumors. Lip...

    Authors: Jens HW Pahl, Kitty MC Kwappenberg, Eleni M Varypataki, Susy J Santos, Marieke L Kuijjer, Susan Mohamed, Juul T Wijnen, Maarten JD van Tol, Anne-Marie Cleton-Jansen, R Maarten Egeler, Wim Jiskoot, Arjan C Lankester and Marco W Schilham
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:27
    Content type: Research Published on:

  4. Stanniocalcin 2 (STC2) is overexpressed in several types of human cancers, and its overexpression positively correlates to tumor progression and poor prognosis. However, the clinical significance of STC2 overe...

    Authors: Shaojun Lin, Qiaojuan Guo, Jiangmei Wen, Chao Li, Jin Lin, Xiaofei Cui, Nianli Sang and Jianji Pan
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:26
    Content type: Research Published on:

  5. Expression of the non-receptor tyrosine kinase ETK/BMX has been reported in several solid tumors, but the underlying molecular mechanisms and its clinical significance in renal cell carcinoma (RCC) remain to b...

    Authors: Jintao Zhuang, Xiangan Tu, Kaiyuan Cao, Shengjie Guo, Xiaopeng Mao, Jincheng Pan, Bin Huang, Xu Chen, Yong Gao and Shaopeng Qiu
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:25
    Content type: Research Published on:

  6. CELLFOOD™ (CF) is a nutraceutical non-addictive, non-invasive, and completely non-toxic unique proprietary colloidal-ionic formula. Little is known about its effect on cancer cells in solid tumors. The aim of ...

    Authors: Barbara Nuvoli, Raffaela Santoro, Simona Catalani, Serafina Battistelli, Serena Benedetti, Franco Canestrari and Rossella Galati
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:24
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2022 41:290

  7. Dystrophic skin scarring commonly occurs following skin cancer resections. In particular, the cosmetic outcome of skin graft reconstructions, following epidermoidal carcinoma removal, is generally poor due to ...

    Authors: Emilia Migliano, Barbara Bellei, Flavio Andrea Govoni, Stefania Bucher and Mauro Picardo
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:23
    Content type: Research Published on:

  8. Authors: Nobuyuki Ehira, Hiroyuki Oshiumi, Misako Matsumoto, Takeshi Kondo, Masahiro Asaka and Tsukasa Seya
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:22
    Content type: Erratum Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2010 29:135

  9. Sunitinib alone exhibits satisfactory efficacy in several mouse homografts and xenografts but unsatisfactory efficacy in many kinds of solid tumors in clinic. Different from animals, receiving a diagnosis of c...

    Authors: Guo-Hua Deng, Jie Liu, Jie Zhang, Ying Wang, Xing-Chen Peng, Yu-Quan Wei and Yu Jiang
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:21
    Content type: Research Published on:

  10. Esophageal squamous cell carcinoma (ESCC) is an aggressive tumor with dismal prognosis and high incidence and mortality in Kazakh population. MiR-34a, a direct p53 target gene, possesses tumor-suppressive prop...

    Authors: Xiaobin Cui, Zhimin Zhao, Dong Liu, Tao Guo, Su Li, Jianming Hu, Chunxia Liu, Lan Yang, Yuwen Cao, Jinfang Jiang, Weihua Liang, Wei Liu, Shugang Li, Lianghai Wang, Lidong Wang, Wenyi Gu…
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:20
    Content type: Research Published on:

  11. Considering previous result in Non-Small Cell Lung Cancer (NSCLC), we investigated in human cancer cells the role of PARP3 in the regulation of telomerase activity.

    Authors: Tamara Fernández-Marcelo, Cristina Frías, Irene Pascua, Carmen de Juan, Jacqueline Head, Ana Gómez, Florentino Hernando, Jose-Ramon Jarabo, Eduardo Díaz-Rubio, Antonio-Jose Torres, Michèle Rouleau, Manuel Benito and Pilar Iniesta
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:19
    Content type: Research Published on:

  12. The chaperon heat shock protein 90 (HSP90) constitutes an important target for anti-tumor therapy due to its essential role in the stabilization of oncogenes. However, HSP90 is ubiquitously active to orchestra...

    Authors: Stefanie Trojandt, Angelika B Reske-Kunz and Matthias Bros
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:16
    Content type: Research Published on:

  14. Over the last decades, billions have been spent and huge efforts have been taken in basic and clinical cancer research [CA Cancer J Clin 63: 11-30]. About a decade ago, the arms race between drugs and cancer cell...

    Authors: Niels Eckstein, Lea Röper, Bodo Haas, Henrike Potthast, Ulrike Hermes, Christoph Unkrig, Frauke Naumann-Winter and Harald Enzmann
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:15
    Content type: Review Published on:

  15. NAD (P) H: quinone oxidoreductase 1 (NQO1) is a xenobiotic metabolizing enzyme that detoxifies chemical stressors and antioxidants, providing cytoprotection in normal tissues. However, high-level expression of...

    Authors: Yang Yang, Yan Zhang, Qunying Wu, Xuelian Cui, Zhenhua Lin, Shuangping Liu and Liyan Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:14
    Content type: Research Published on:

  16. Colorectal cancer is the third most commonly diagnosed cancer worldwide. Although surgery remains the best treatment for this disease, adjuvant chemotherapy and radiotherapy are also very important in clinical...

    Authors: Xiaoyu Wu, Wentao Liu, Qinhong Cao, Che Chen, Zhiwei Chen, Zhe Xu, Weisu Li, Fukun Liu and Xuequan Yao
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:13
    Content type: Research Published on:

  17. miRNAs are involved in osteosarcoma (OS) chemoresistance, and TWIST reportedly enhances cisplatin-induced OS cell apoptosis by inhibiting multiple signaling pathways. In this study, we profiled miRNAs differen...

    Authors: Yong Zhou, Zufa Huang, Song Wu, Xiaofang Zang, Min Liu and Jian Shi
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:12
    Content type: Research Published on:

  18. Cholangiocarcinoma (CCA) is highly resistant to most of the known chemotherapeutic treatments. NAD(P)H-quinone oxidoreductase 1 (NQO1) is an antioxidant/detoxifying enzyme recently recognized as an important c...

    Authors: Ponsilp Zeekpudsa, Veerapol Kukongviriyapan, Laddawan Senggunprai, Banchob Sripa and Auemduan Prawan
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:11
    Content type: Research Published on:

  19. ErbB4 expression has been noted in various tumors, but its regulatory mechanism in esophageal squamous cell carcinoma (ESCC) remains unclear. The aim of this study was to investigate whether miR-302b regulates...

    Authors: Mingxin Zhang, Qi Yang, Lingmin Zhang, Suna Zhou, Wenguang Ye, Qinglin Yao, Zongfang Li, Cheng Huang, Qinsheng Wen and Jingjie Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:10
    Content type: Research Published on:

  20. Glioblastoma multiforme (GBM) is the most malignant type of glioma. Integrated classification based on mRNA expression microarrays and whole–genome methylation subdivides GBM into five subtypes: Classical, Mes...

    Authors: Rui Li, Kaiming Gao, Hui Luo, Xiefeng Wang, Yan Shi, Qingsheng Dong, WenKang Luan and Yongping You
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:9
    Content type: Research Published on:

  21. c-Jun NH2-terminal kinases (JNKs) are strongly activated by a stressful cellular environment, such as chemotherapy and oxidative stress. Autophagy is a protein-degradation system in which double-membrane vacuo...

    Authors: Guang Jia, Rui Kong, Zhi-Bin Ma, Bing Han, Yong-Wei Wang, Shang-Ha Pan, Ying-Hua Li and Bei Sun
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:8
    Content type: Research Published on:

  22. The mechanism for inactivation of positive regulatory domain containing I (PRDM1), a newly identified tumour suppressor gene in extranodal NK/T-cell lymphoma, nasal type (EN-NK/T-NT) has not been well defined....

    Authors: Li Liang, Lin Nong, Shuang Zhang, Jing Zhao, Hongjuan Ti, Ying Dong, Bo Zhang and Ting Li
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:7
    Content type: Research Published on:

  23. Hec1 (NDC80) is an integral part of the kinetochore and is overexpressed in a variety of human cancers, making it an attractive molecular target for the design of novel anticancer therapeutics. A highly potent...

    Authors: Lynn YL Huang, Ying-Shuan Lee, Jiann-Jyh Huang, Chia-chi Chang, Jia-Ming Chang, Shih-Hsien Chuang, Kuo-Jang Kao, Yung-Jen Tsai, Pei-Yi Tsai, Chia-Wei Liu, Her-Sheng Lin and Johnson YN Lau
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:6
    Content type: Research Published on:

  24. EGFR mutation detection has been widely applied in the prediction of TKIs therapy in Non-Small Cell Lung Cancer (NSCLC). Metastatic tumors rather than primary tumors were usually assayed for those patients in ...

    Authors: Bing Wei, Ke Yang, Jiuzhou Zhao, Yuxi Chang, Zihui Ma, Bing Dong, Yongjun Guo and Jie Ma
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:5
    Content type: Research Published on:

  25. Colorectal cancer (CRC) arises as a consequence of genetic events such as gene mutation and epigenetic alteration. The aim of this study was to identify new hypermethylated candidate genes and methylation-base...

    Authors: Ji Wook Moon, Soo Kyung Lee, Jung Ok Lee, NamI Kim, Yong Woo Lee, Su Jin Kim, Ho Jin Kang, Jin Kim, Hyeon Soo Kim and Sun-Hwa Park
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:4
    Content type: Research Published on:

  26. Parthenolide (PTL) is a sesquiterpene lactone which can induce apoptosis in cancer cells and eradicate cancer stem cells such as leukemia stem cells, prostate tumor-initiating cells and so on. However, the mec...

    Authors: Xiaofei Zhao, Xiangguo Liu and Ling Su
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:3
    Content type: Research Published on:

  27. Gastric cancers have poor overall survival despite recent advancements in early detection methods, endoscopic resection techniques, and chemotherapy treatments. Vaccinia viral therapy has had promising therape...

    Authors: Kyong-Hwa Jun, Sepideh Gholami, Tae-Jin Song, Joyce Au, Dana Haddad, Joshua Carson, Chun-Hao Chen, Kelly Mojica, Pat Zanzonico, Nanhai G Chen, Qian Zhang, Aladar Szalay and Yuman Fong
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:2
    Content type: Research Published on:

  28. Several studies evaluated the prevalence of Lynch Syndrome (LS) in young onset colorectal cancer (CRC) patients and the results were extremely variable (5%-20%). Immunohistochemistry (IHC) for MMR proteins and...

    Authors: Vittoria Stigliano, Lupe Sanchez-Mete, Aline Martayan, Maria Diodoro, Beatrice Casini, Isabella Sperduti and Marcello Anti
    Citation: Journal of Experimental & Clinical Cancer Research 2014 33:1
    Content type: Research Published on:

  29. To assess the efficacy of intraoperative ultrasound-guided implantation of 125I seeds for the treatment of unresectable pancreatic carcinoma, and analyze the associated prognostic factors.

    Authors: Hao Wang, Junjie Wang, Yuliang Jiang, Jinna Li, Suqing Tian, Weiqiang Ran, Dianrong Xiu and Yang Gao
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:106
    Content type: Research Published on:

  30. Numerous studies have yielded inconclusive results regarding the relationship between anti-apoptotic protein Bcl-2 expression and the sensitivity to chemotherapy in the patients with breast cancer. The purpose...

    Authors: Dong Yang, Min-Bin Chen, Li-Qiang Wang, Lan Yang, Chao-Ying Liu and Pei-Hua Lu
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:105
    Content type: Review Published on:

  31. Genome-wide association studies have identified that genetic variants in 8q24 confer susceptibility to colorectal cancer (CRC). Recently, a novel lncRNA (PRNCR1) that located in the 8q24 was discovered. Single nu...

    Authors: Lijuan Li, Ruifen Sun, Yundan Liang, Xinmin Pan, Zhaohui Li, Peng Bai, Xiaofeng Zeng, Dongxian Zhang, Lin Zhang and Linbo Gao
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:104
    Content type: Research Published on:

  32. To investigate the feasibility of dose escalation (86 Gy at 2 Gy/fraction) with intensity modulated radiation therapy (IMRT) in intermediate-risk prostate cancer without androgen deprivation therapy.

    Authors: Maria Grazia Petrongari, Valeria Landoni, Biancamaria Saracino, Sara Gomellini, Stefano Arcangeli, Giuseppe Iaccarino, Paola Pinnarò, Giorgio Arcangeli and Lidia Strigari
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:103
    Content type: Research Published on:

  33. Both BRCA1 and epidermal growth factor receptor (EGFR) play a critical role in ovarian cancer progression. However, the crosstalk between BRCA1 and EGFR signaling pathways in ovarian cancer remains largely unk...

    Authors: Da Li, Fang-Fang Bi, Ji-Min Cao, Chen Cao, Chun-Yan Li and Qing Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:102
    Content type: Research Published on:

  34. Recently, leucine-rich repeats and immunoglobulin-like domains 1 (LRIG1), a negative regulator of EGFR, was discovered is a novel agent for suppressing bladder cancer. The aim of this study was to investigate ...

    Authors: Lei Chang, Runlin Shi, Tao Yang, Fan Li, Guohao Li, Yonglian Guo, Bin Lang, Weimin Yang, Qianyuan Zhuang and Hua Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:101
    Content type: Research Published on:

  35. Neuroblastoma (NB) is the most common extracranial solid tumor in childhood. The present treatment including surgery, chemotherapy and radiation, which have only 40% long-term cure rates, and usually cause tum...

    Authors: Xiao-Hong Tian, Wei-Jian Hou, Yan Fang, Jun Fan, Hao Tong, Shu-Ling Bai, Qu Chen, He Xu and Yan Li
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:100
    Content type: Research Published on:

  36. Paclitaxel, a widely used chemotherapeutic drug, can induce apoptosis in variety of cancer cells. A previous study has shown preferential toxicity of paclitaxel to FLCN-deficient kidney cancer cell line, UOK25...

    Authors: Qi Zhang, Shuhui Si, Sue Schoen, Jindong Chen, Xun-Bo Jin and Guan Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:99
    Content type: Research Published on:

  37. Mir-29 microRNA families are involved in regulation of various types of cancers. Although Mir-29 was shown to play an inhibitory role in tumorigenesis, the role of Mir-29 in breast cancer still remains obscure...

    Authors: Zhenglong Wu, Xiaona Huang, Xing Huang, Qiang Zou and Yujiang Guo
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:98
    Content type: Research Published on:

  38. Interleukin-27 signaling is mediated by the JAK-STAT pathway via activation of STAT1 and STAT3, which have tumor suppressive and oncogenic activities, respectively. Epithelial–mesenchymal transition (EMT) and ...

    Authors: Puja Kachroo, Mi-Heon Lee, Ling Zhang, Felicita Baratelli, Gina Lee, Minu K Srivastava, Gerald Wang, Tonya C Walser, Kostyantyn Krysan, Sherven Sharma, Steven M Dubinett and Jay M Lee
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:97
    Content type: Research Published on:

  39. Similar to protein-coding genes, miRNAs are also susceptible to epigenetic modulation. Although numerous miRNAs have been shown to be affected by DNA methylation, the regulatory mechanism of histone modificati...

    Authors: Xiaolan Liu, Xiaoyan Chen, Xinfang Yu, Yongguang Tao, Ann M Bode, Zigang Dong and Ya Cao
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:96
    Content type: Review Published on:

  40. Mutations in the DNA damage response (DDR) factors, breast cancer 1 (BRCA1) and BRCA2, sensitize tumor cells to poly(ADP-ribose) polymerase (PARP) inhibitors. The ataxia telangiectasia mutated (ATM) kinase is ...

    Authors: Maria Saveria Gilardini Montani, Andrea Prodosmo, Venturina Stagni, Dania Merli, Laura Monteonofrio, Veronica Gatti, Maria Pia Gentileschi, Daniela Barilà and Silvia Soddu
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:95
    Content type: Research Published on:

  41. Although non muscle invasive bladder cancer (NMIBC) generally has a good long-term prognosis, up to 80% of patients will nevertheless experience local recurrence after the primary tumor resection. The search f...

    Authors: Valentina Casadio, Chiara Molinari, Daniele Calistri, Michela Tebaldi, Roberta Gunelli, Luigi Serra, Fabio Falcini, Chiara Zingaretti, Rosella Silvestrini, Dino Amadori and Wainer Zoli
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:94
    Content type: Research Published on:

  42. Antiangiogenic treatment may change the tumor microenvironment and hence influence the effect of conventional therapies. The potential of diffusion weighted magnetic resonance imaging (DW-MRI) and dynamic cont...

    Authors: Jon-Vidar Gaustad, Viktoria Pozdniakova, Tord Hompland, Trude G Simonsen and Einar K Rofstad
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:93
    Content type: Research Published on:

  43. Fluoropyrimidines, oxaliplatin, irinotecan and biologic therapies (Bevacizumab, Panitumumab, and Cetuximab) represent the backbone of metastatic colorectal cancer (CRC) treatment. The improvement in survival f...

    Authors: Giuseppe Tonini, Marco Imperatori, Bruno Vincenzi, Anna Maria Frezza and Daniele Santini
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:92
    Content type: Review Published on:

  44. One of the key oncogenic pathways involved in melanoma aggressiveness, development and progression is the RAS/BRAF/MEK pathway, whose alterations are found in most patients. These molecular anomalies are promi...

    Authors: Giovanni Sette, Katia Fecchi, Valentina Salvati, Fiorenza Lotti, Emanuela Pilozzi, Enrico Duranti, Mauro Biffoni, Alfredo Pagliuca, Daniela Martinetti, Lorenzo Memeo, Michele Milella, Ruggero De Maria and Adriana Eramo
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:91
    Content type: Research Published on:

  45. The principal Epstein–Barr virus (EBV) oncoprotein, latent membrane protein 1 (LMP1) is strongly associated with nasopharyngeal carcinoma (NPC), a prevalent cancer in China. The epidermal growth factor recepto...

    Authors: Yang Xu, Ying Shi, Qi Yuan, Xuli Liu, Bin Yan, Ling Chen, Yongguang Tao and Ya Cao
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:90
    Content type: Research Published on:

  46. The effectiveness of different breast cancer follow-up procedures to decrease breast cancer mortality are still an object of debate, even if intensive follow-up by imaging modalities is not recommended by inte...

    Authors: Isabella Sperduti, Patrizia Vici, Nicola Tinari, Teresa Gamucci, Michele De Tursi, Giada Cortese, Antonino Grassadonia, Stefano Iacobelli and Clara Natoli
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:89
    Content type: Review Published on:

  47. To investigate the potential dosimetric and clinical benefits of Deep Inspiration Breath-Hold (DIBH) technique during radiotherapy of breast cancer compared with Free Breathing (FB).

    Authors: Vicente Bruzzaniti, Armando Abate, Paola Pinnarò, Marco D’Andrea, Erminia Infusino, Valeria Landoni, Antonella Soriani, Carolina Giordano, Anna Maria Ferraro and Lidia Strigari
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:88
    Content type: Research Published on:

  48. To evaluate the prognostic role of TAMs in patients affected by non-muscle invasive bladder cancer (NMIBC), undergone Trans Urethral Resection of Bladder (TURB) and Bacillus Calmette-Guerin (BCG) therapy.

    Authors: Francesca Suriano, Daniele Santini, Giuseppe Perrone, Michela Amato, Bruno Vincenzi, Giuseppe Tonini, Andrea Onetti Muda, Sara Boggia, Maurizio Buscarini and Francesco Pantano
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:87
    Content type: Research Published on:

  49. Altered gene methylation, regulated by DNA methyltransferases (DNMT) 1, 3a and 3b, contributes to tumorigenesis. However, the role of DNMT in pancreatic ductal adenocarcinoma (PDAC) remains unknown.

    Authors: Jun Gao, Lihua Wang, Jinkang Xu, Jianming Zheng, Xiaohua Man, Hongyu Wu, Jin Jin, Kaixuan Wang, Huasheng Xiao, Shude Li and Zhaoshen Li
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:86
    Content type: Research Published on:

  50. The SNP309 polymorphism (T-G) in the promoter of MDM2 gene has been reported to be associated with enhanced MDM2 expression and tumor development. Studies investigating the association between MDM2 SNP309 poly...

    Authors: Qiliu Peng, Cuiju Mo, Aiping Qin, Xianjun Lao, Zhiping Chen, Jingzhe Sui, Junrong Wu, Limin Zhai, Shi Yang, Xue Qin and Shan Li
    Citation: Journal of Experimental & Clinical Cancer Research 2013 32:85
    Content type: Research Published on:

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us